New Jersey Administrative Code
Title 10 - HUMAN SERVICES
Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES
Subchapter 11 - OPIOID TREATMENT SERVICES
Section 10:161B-11.11 - Labeling of take-home medication
Universal Citation: NJ Admin Code 10:161B-11.11
Current through Register Vol. 56, No. 18, September 16, 2024
(a) Take-home medication provided to eligible clients shall be provided in a child-proof container in accordance with the Poison Prevention Packaging Act ( PL 91-601, 15 U.S.C. 1471, Federal Consumer Product Safety Commission, http://www.cpsc.gov//Global/PDF/Statues/pppa.pdf and shall be labeled as follows:
Name, address, and telephone number of the opioid treatment program
Date of issue
Client's full name
Name and strength of drug
Number of doses, if multiple dose
Directions for use
Name of prescribing Physician or advanced practice nurse
Warning/caution statement
Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.